granisetron hydrochloride nasal spray
Term · Oncology and biomedicine · MLC-T-ONC-014028
An intranasal formulation containing the hydrochloride salt form of the indazole derivative granisetron, a selective serotonin (5-hydroxytryptamine; 5-HT) receptor antagonist, with antinauseant and antiemetic activities. Upon administration to the nostril, granisetron selectively binds to and inhibits 5-HT subtype 3 receptors (5-HT3R) located peripherally on vagus nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema, which may result in suppression of chemotherapy-induced nausea and vomiting (CINV).
| Identifier | MLC-T-ONC-014028 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | GNS |
| Synonyms | intranasal granisetron hydrochloride; granisetron HCl nasal spray |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014028",
"term": "granisetron hydrochloride nasal spray",
"field": "Oncology and biomedicine",
"definition": "An intranasal formulation containing the hydrochloride salt form of the indazole derivative granisetron, a selective serotonin (5-hydroxytryptamine; 5-HT) receptor antagonist, with antinauseant and antiemetic activities. Upon administration to the nostril, granisetron selectively binds to and inhibits 5-HT subtype 3 receptors (5-HT3R) located peripherally on vagus nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema, which may result in suppression of chemotherapy-induced nausea and vomiting (CINV).",
"abbreviation": "GNS",
"synonyms": [
"intranasal granisetron hydrochloride",
"granisetron HCl nasal spray"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/granisetron-hydrochloride-nasal-spray/"
}
Record 8,178 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.